Skip to main content Help with accessibility Skip to main navigation

Duloxetine

Indication

Depressive illness, generalised anxiety disorder

MHRA Drug Safety Update - Duloxetine: regular assessment for suicidal ideation

Amber level 0

Brand:

Cymbalta®

Nice TA:

Commissioning responsibility:

CCG

PbR excluded:

No

BNF chapter:
Central nervous system

Background

LSCMMG is adopting the local decision made prior to April 2013
Reason for decision:  The colour classification was determined as part of the collaborative work between LCFT and medicines Management leads. Local pathways and patient safety were taken into consideration.

Recommendation

LSCMMG Recommendation:

Amber level 0

Reason for decision:

Suitable for GP prescribing following recommendation/initiation by specialist

Supporting documents:

Decisions of Lancashire local decision making groups

Amber 0
Pending
Amber 0
Amber 0
Green
Amber 0
Amber 0
Pending
What do the colours mean?

Last Updated: 01 - May - 2013